Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	370.04	411.29	351.19	551.8	640.19	565.78
Short-Term Investments	4.75	4.85	4.35	6.51	61.04	311.87
Cash & Short-Term Investments	374.78	416.14	355.54	558.31	701.23	877.65
Cash Growth	1.83%	17.04%	-36.32%	-20.38%	-20.10%	149.34%
Accounts Receivable	229.23	271.72	224.5	29.17	80.1	25
Other Receivables	-	-	-	8.71	-	-
Receivables	229.23	271.72	224.5	37.88	80.1	25
Inventory	121.24	82.48	162.66	99.7	24	-
Prepaid Expenses	13.47	9.51	8.59	7.18	5.17	3.4
Restricted Cash	1.43	1.32	1.11	1.27	1.56	1.27
Other Current Assets	15.47	7.78	13.93	15.18	11.98	9.88
Total Current Assets	755.61	788.95	766.33	719.52	824.05	917.19
Property, Plant & Equipment	16.75	19.04	21.09	24.9	26.08	24.52
Long-Term Accounts Receivable	-	-	-	15	30	18
Other Long-Term Assets	49.03	77.06	1.31	0.8	1.64	0.86
Total Assets	821.39	885.05	788.73	760.22	881.77	960.57
Accounts Payable	54.24	38.57	37.52	37.34	16.91	8.48
Accrued Expenses	139	140.18	127.81	95.14	103.24	111.94
Current Portion of Leases	7.42	6.75	6.44	5.63	4.12	3.69
Other Current Liabilities	-	-	75.83	29.5	7.58	4.23
Total Current Liabilities	200.66	185.51	247.59	167.61	131.85	128.33
Long-Term Debt	454.04	452.83	93.03	92.74	189.02	358.83
Long-Term Leases	8.31	10.2	11.45	14.35	17.08	15.22
Other Long-Term Liabilities	2.08	7.97	242.13	315.65	345.15	253.64
Total Liabilities	665.09	656.51	594.21	590.35	683.1	756.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,329	3,267	3,036	2,480	1,857	1,131
Retained Earnings	-3,170	-3,035	-2,837	-2,309	-1,657	-926.35
Comprehensive Income & Other	-2.57	-3.31	-3.54	-0.88	-2.09	-0.12
Total Common Equity	156.31	228.54	194.52	169.87	198.66	204.56
Shareholders' Equity	156.31	228.54	194.52	169.87	198.66	204.56
Total Liabilities & Equity	821.39	885.05	788.73	760.22	881.77	960.57
Total Debt	469.77	469.78	110.93	112.71	210.22	377.73
Net Cash (Debt)	-94.99	-53.65	244.61	445.59	491.01	499.92
Net Cash Growth	-	-	-45.10%	-9.25%	-1.78%	156.43%
Net Cash Per Share	-0.76	-0.43	2.06	4.20	5.82	6.65
Filing Date Shares Outstanding	126.29	125.52	120.58	111.29	97.73	80.38
Total Common Shares Outstanding	126.19	124.5	119.56	110.77	97.52	76.13
Working Capital	554.95	603.45	518.74	551.91	692.2	788.87
Book Value Per Share	1.24	1.84	1.63	1.53	2.04	2.69
Tangible Book Value	156.31	228.54	194.52	169.87	198.66	204.56
Tangible Book Value Per Share	1.24	1.84	1.63	1.53	2.04	2.69

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q